EPO Patents = 2

Forward Citations = 56

Loading Chart...

3 inventors (with patents filed for the assignee):

Radhakrishnan P Iyer (9 out of 37 patents)

Seetharamaiyer Padmanabhan (8 out of 15 patents)

John E Coughlin (1 out of 1 patent)

9 patents: Sort by Forward Citations

1. 10376533 - Compositions and methods for treating viral infections (2019-08-13),

2. 10344046 - Nucleotide and oligonucleotide prodrugs (2019-07-09),

3. 10047114 - Nucleotide and oligonucleotide prodrugs (2018-08-14),

4. 9539276 - Compositions and methods for treating viral infections (2017-01-10),

5. 9138442 - Compositions and methods for treating viral infections (2015-09-22),

6. 9040234 - Oligonucleotide analogs as therapeutic agents (2015-05-26),

7. 8691787 - Nucleotide and oligonucleotide prodrugs (2014-04-08),

8. 8404651 - Compositions and methods for treating viral infections (2013-03-26),

9. 8076303 - Nucleotide and oligonucleotide prodrugs (2011-12-13),

Spring Bank Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of viral infections, cancer, and inflammatory diseases. The company's lead product candidate, inarigivir, is being developed for the treatment of chronic hepatitis B virus (HBV) infection. Spring Bank is committed to delivering innovative solutions to improve patients' lives.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

9 Patents

#8 in Hopkinton, MA

#1,863 in Massachusetts

#31,581 in US

Hopkinton, MA, United States of America

Spring Bank Pharmaceuticals, Inc.

Forward Citations = 56

3 inventors:

Radhakrishnan P Iyer (9 out of 37 patents)

Seetharamaiyer Padmanabhan (8 out of 15 patents)

John E Coughlin (1 out of 1 patent)

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com